BrightPath Biotherapeutics (Japan)

Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma

Diwakar Davar, Hong Wang, Joe-Marc Chauvin et al. · Journal of Clinical Oncology · 2018 · 79 citations · Full text

Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype

Kayoko Nakamura, Shigeki Yagyu, Shogo Hirota et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 30 citations · Full text

Autologous Antigen-presenting Cells, Immunology, Antigen Processing +6

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations

Susumu Iiizumi, Junya Ohtake, Naoko Murakami et al. · Cancers · 2019 · 28 citations · Full text

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response

Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi et al. · OncoImmunology · 2020 · 27 citations · Full text

Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation

Feifei Wei, Taku Kouro, Yuko Nakamura et al. · Computational and Structural Biotechnology Journal · 2024 · 14 citations · Full text